Synerginex

Tag Name: Synerginex

Discover Synerginex — a novel antibiotic adjuvant engineered to restore the effectiveness of existing antibiotics against multidrug-resistant organisms.

Introduction

Synerginex is an innovative antibiotic adjuvant formulation designed to combat the growing global threat of antimicrobial resistance.

Rather than replacing current antibiotics, Synerginex works synergistically with them — restoring their lost activity against multidrug-resistant bacteria. By enhancing antibiotic performance, this formulation helps overcome resistance mechanisms and improves therapeutic outcomes.

The proof of concept has demonstrated restored antibiotic efficacy against resistant pathogens. Since the formulation components are FDA-approved materials, Synerginex presents strong potential for rapid clinical translation and scalable commercialization (TRL 5)

Inventors

1 Dr. Susu Zughaier

2 Mohammed Uddin

3 Maryam Hassiba

4 College of Medicine, Qatar University

Main Features

Antibiotic Activity Restoration

Reactivates the effectiveness of existing antibiotics against resistant bacteria.

Synergistic Mechanism

Enhances antibiotic performance without requiring new antibiotic discovery.

Scalable & Translational

Built using approved materials to accelerate regulatory pathways.

Broad Application Potential

Applicable across human health, veterinary medicine, and pharmaceutical sectors.

Strategic Opportunities

Healthcare & Antimicrobial Resistance (AMR)

Addresses one of the most urgent global health threats.

Veterinary & Animal Health Sector

Strong revenue potential within the GCC market.

Pharmaceutical Partnerships

Opportunity for co-formulation with existing antibiotic products.

Global Health Deployment

Supports international efforts to reduce antibiotic resistance.

Value Proposition

Extends the Life of Existing Antibiotics

Reduces the need for costly new antibiotic development.

Cost-Effective Solution

Enhances current treatments rather than replacing them.

Regulatory Advantage

Utilizes safe, approved materials for faster translation.

Market Potential

Estimated strong revenue potential within regional and global markets.

Status of the Invention

Provisional US Patent

Proof-of-concept validated

Technology Readiness Level: TRL 5

Invitation to Industry — Collaborate With Us

Join us in restoring the power of antibiotics. Synerginex is ready for:

Licensing & commercialization

Pharmaceutical co-development

Clinical validation partnerships

Veterinary health deployment

Global AMR strategy integration

With strong research backing from Qatar University, Synerginex represents a strategic solution to one of the world’s most pressing healthcare challenges.

Image Viewer